It was found that after blocking NLRP3, the effects above after IL-17A stimulation was weakened, confirming that IL-17A can promote the migration, invasion and the EMT process of lung cancer cells by activating NLRP3 in vitro. This evidence concerns the gene NLRP3 and lung carcinoma.